Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Scott Turner

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Neurobiology of Disease|July 28, 2009
X11alpha haploinsufficiency enhances Abeta amyloid deposition in Alzheimer's disease transgenic miceInderjeet Saluja, Henry Paulson, Ashwin Gupta, et al.
Frontiers in Neuroscience|June 12, 2023
Matrix disequilibrium in Alzheimer's disease and conditions that increase Alzheimer's disease riskMatthew Amontree, Samantha Deasy, R Scott Turner, et al.
Learning & Memory (Cold Spring Harbor, N.Y.)|October 3, 2002
Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's diseaseKevin A Corcoran, Ye Lu, R Scott Turner, et al.
Frontiers in Neurology|June 26, 2020
Potential New Approaches for Diagnosis of Alzheimer's Disease and Related DementiasR Scott Turner, Terry Stubbs, Don A Davies, et al.
Neuropsychological Rehabilitation|January 31, 2018
Long-Term maintenance of anomia treatment effects in primary progressive aphasiaAaron M Meyer, Donna C Tippett, R Scott Turner, et al.
Neurocase|April 18, 2012
Coexisting adult polyglucosan body disease with frontotemporal lobar degeneration with transactivation response DNA-binding protein-43 (TDP-43)-positive neuronal inclusionsJill G Farmer, Barbara J Crain, Brent T Harris, et al.
Digital Health|May 6, 2021
Acceptability of collecting speech samples from the elderly via the telephoneCatherine Diaz-Asper, Chelsea Chandler, R Scott Turner, et al.
Journal of Pharmacy Practice|December 4, 2012
Pharmacist-developed sedation protocol and impact on ventilator daysLindsay Hahn, Jennifer Beall, R Scott Turner, et al.
Aging and Disease|April 5, 2021
Nilotinib Improves Bioenergetic Profiling in Brain Astroglia in the 3xTg Mouse Model of Alzheimer's DiseaseAida Adlimoghaddam, Gary G Odero, Gordon Glazner, et al.
Clinical Trials (London, England)|January 11, 2021
Research Attitudes Questionnaire scores predict Alzheimer's disease clinical trial dropoutShana D Stites, R Scott Turner, Jeanine Gill, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Neurobiology of Disease|July 28, 2009
X11alpha haploinsufficiency enhances Abeta amyloid deposition in Alzheimer's disease transgenic miceInderjeet Saluja, Henry Paulson, Ashwin Gupta, et al.
Frontiers in Neuroscience|June 12, 2023
Matrix disequilibrium in Alzheimer's disease and conditions that increase Alzheimer's disease riskMatthew Amontree, Samantha Deasy, R Scott Turner, et al.
Learning & Memory (Cold Spring Harbor, N.Y.)|October 3, 2002
Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's diseaseKevin A Corcoran, Ye Lu, R Scott Turner, et al.
Frontiers in Neurology|June 26, 2020
Potential New Approaches for Diagnosis of Alzheimer's Disease and Related DementiasR Scott Turner, Terry Stubbs, Don A Davies, et al.
Neuropsychological Rehabilitation|January 31, 2018
Long-Term maintenance of anomia treatment effects in primary progressive aphasiaAaron M Meyer, Donna C Tippett, R Scott Turner, et al.
Neurocase|April 18, 2012
Coexisting adult polyglucosan body disease with frontotemporal lobar degeneration with transactivation response DNA-binding protein-43 (TDP-43)-positive neuronal inclusionsJill G Farmer, Barbara J Crain, Brent T Harris, et al.
Digital Health|May 6, 2021
Acceptability of collecting speech samples from the elderly via the telephoneCatherine Diaz-Asper, Chelsea Chandler, R Scott Turner, et al.
Journal of Pharmacy Practice|December 4, 2012
Pharmacist-developed sedation protocol and impact on ventilator daysLindsay Hahn, Jennifer Beall, R Scott Turner, et al.
Aging and Disease|April 5, 2021
Nilotinib Improves Bioenergetic Profiling in Brain Astroglia in the 3xTg Mouse Model of Alzheimer's DiseaseAida Adlimoghaddam, Gary G Odero, Gordon Glazner, et al.
Clinical Trials (London, England)|January 11, 2021
Research Attitudes Questionnaire scores predict Alzheimer's disease clinical trial dropoutShana D Stites, R Scott Turner, Jeanine Gill, et al.
Pageof 7